Renal disease in Henoch Schonlein Purpura

9 Sep, 08 | by Ian Wacogne

A systematic review of ten trials conducted on therapies to try to reduce renal disease in HSP shows very little evidence for any modality, although short-term prednisolone is specfically not helpful. Here.

Posted in Nephrology.

Respond

Print page

Rights and permissions

By submitting your comment you agree to adhere to these terms and conditions

You can follow any responses to this entry through the RSS 2.0 feed.

ADC Online

A peer review journal for health professionals and researchers covering conception to adolescence. Visit site

Categories
- Allergy (7)
- Cardiology (12)
- Child Protection (10)
- Clinical Governance (2)
- Dermatology (4)
- Development (27)
- Editor's Choice (2)
- Education (5)
- Emergency Care (6)
- Endocrinology (27)
- ENT (6)
- Epidemiology (4)
- Ethics (2)
- Gastroenterology (15)
- Genetics (7)
- Global Child Health (7)
- Growth (8)
- Haematology (9)
- High Dependency and Intensive Care (4)
- Immunisation (18)
- Infectious Disease (49)
- Information Technology (3)
- Interpretations (1)
- Issue (10)
- Leading Article (20)
- Mental Health (6)
- Metabolic (1)
- Neonatology (14)
- Nephrology (8)
- Neurology (5)
- Nutrition (14)
- Obesity (24)
- Oncology (5)
- Ophthalmology (1)
- Orthopaedics (1)
- Palliative Care (2)
- Perspective (26)
- Pharmacology (19)
- Podcast (1)
- Psychiatry (4)
- Quality of life (3)
- Radiology (1)
- Respiratory (38)
- Rheumatology (2)
- Sudden Infant Death (9)
- Surgery (2)
- Surveillance (17)
- Trauma (3)
- Uncategorized (6)
Browse our archives
Pages

BMJ Group blogs

ADC Precis